Syqe Medical Named to Fast Company's Annual List of the World's Most Innovative Companies for 2020
TEL AVIV, Israel, March 11, 2020 /PRNewswire/ -- Syqe Medical announced today that it has been ranked in Fast Company's top 10 Biotech companies in the prestigious annual 2020 Most Innovative Companies List. The list honors the businesses making the most profound impact on both industry and culture, showcasing a variety of ways to thrive in today's fast-changing world. This year's list features 434 businesses from 39 countries.
Syqe Medical is an Israeli pharma-tech company developing technologies for the administration of raw plants and pharmaceuticals by inhalation. The company has developed the world's first programmable pulmonary drug delivery platform, the Syqe Inhaler™, capable of administering metered doses of plants at therapeutic standards. First brought to market for use with cannabinoids, Syqe is exploring numerous molecules for a variety of therapeutic areas and is seeking strategic partnerships with leading drug manufacturers and academic centers dedicated to jointly solving the challenges of inadequate therapeutic delivery and dosing.
"Syqe Medical is excited to be named by Fast Company in their annual top ten list of the world's most innovative biotechnology companies," said Perry Davidson, Syqe CEO and Founder. "The technology behind the Syqe Inhaler™ has been proven in several clinical trials demonstrating that the device delivers medication in a safe fashion with breakthrough precision and with consistent and repeatable accuracy. The Syqe device allows patients to receive the clinical benefits of medical cannabis treatment while minimizing the psychoactive side effects. For the first time, healthcare practitioners can prescribe medical cannabis safely, with a defined dosage plan and a predictable outcome - as they would any other pharmaceutical product. What's most important for us is that Syqe's technology is changing patients' lives today," Davidson added.
Syqe's patented technology introduces unprecedented precision dose control as well as inhalation automation that ensures bioavailability with normal inhalation, and remote clinical monitoring. These controls allow for the consistent release and absorption of therapeutic compounds in an aerosol form, generated in milliseconds, addressing significant shortcomings of current inhalers. The inhaler can deliver individually tailored daily treatment plans based on a patient's clinical needs, while ensuring a consistent uniform pharmacokinetic profile. The Syqe Inhaler™ is used with preloaded cartridges of medical cannabis produced under pharmaceutical standards.
In addition to providing maximum symptom relief in minutes while minimizing side effects, the Syqe Inhaler™ drastically reduces the average monthly amount of cannabis required when compared to smoking and vaporizing. Clinical and post-market data shows patients are achieving significant symptom relief while using up to 90 percent less medical cannabis and reducing other medications, such as opioids.
"Using Syqe's breakthrough drug delivery platform, we believe we can vastly improve patient adherence and treatment outcomes across a range of therapeutic areas," said Davidson. "Ultimately, we aim to relieve the suffering of as many patients as possible, in the fastest possible way."
The World's Most Innovative Companies is Fast Company's signature franchise and one of its most highly anticipated editorial efforts of the year. It provides both a snapshot and a road map for the future of innovation across the most dynamic sectors of the economy.
"At a time of increasing global volatility, this year's list showcases the resilience and optimism of businesses across the world. These companies are applying creativity to solve challenges within their industries and far beyond," said Fast Company senior editor Amy Farley, who oversaw the issue with deputy editor David Lidsky.
Fast Company's Most Innovative Companies issue (March/April 2020) is now available online at fastcompany.com/most-innovative-companies/2020, as well as in app form via iTunes and on newsstands beginning March 17, 2020. The hashtag is #FCMostInnovative.
ABOUT SYQE MEDICAL
Syqe Medical is a pharma-tech company developing technologies that enable precise delivery of a wide range of therapeutic molecules by inhalation. Its flagship product, the Syqe Inhaler™, is the first of its kind medical device to provide predictable, precise, and consistent treatment at pharmaceutical standards. Unlike traditional inhalers, Syqe's breakthrough drug delivery technology introduces precision dose control, accurate electronic selective dosing, inhalation automation that ensures bioavailability with natural inspiration, and remote clinical monitoring. Utilizing this breakthrough technology, Syqe aims to relieve the suffering of as many patients as possible in the fastest possible way.
First brought to market for use with medical cannabis, Syqe is exploring numerous molecules for a variety of therapeutic areas including - but not limited to - pain, CNS disorders, sleep, anxiety, and cancer.
Syqe was founded in 2011 and is headquartered in Tel Aviv, Israel with offices in New York and Canada. Approved by the Israeli Ministry of Health, the Syqe Inhaler™ is currently marketed by Teva Pharmaceuticals in Israel. For more information, visit www.syqemedical.com
ABOUT FAST COMPANY
Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. Since 2011, Fast Company has received some of the most prestigious editorial and design accolades, including the American Society of Magazine Editors (ASME) National Magazine Award for "Magazine of the Year," Adweek's Hot List for "Hottest Business Publication," and six gold medals and 10 silver medals from the Society of Publication Designers. The editor-in-chief is Stephanie Mehta and the publisher is Amanda Smith. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication Inc., and can be found online at www.fastcompany.com.
Media Contact
Melyssa Weible
Elixir Health Public Relations
Ph: (1) 201-723-5805
E: [email protected]
SOURCE Syqe Medical
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article